出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年2月
Home Healthcare Market – Global Forecast To 2028
ホームヘルスケア市場 : 製品（透析装置、人工呼吸器、HIV検査キット、補聴器、活動量計）、サービス（高度看護、点滴療法、緩和ケア）、適応症（がん、創傷ケア、糖尿病）、地域別 – 2028年までの世界予測
Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region- Global Forecast to 2028
| ページ数 | 342 |
| 図表数 | 334 |
| 種別 | 英文調査報告書 |
| 価格 |
世界のホームヘルスケア市場は2023年に2,500億ドル規模となり、予測期間中にCAGR 8.9%で成長し、2028年までに3,830億ドルに達するとMarketsandMarketsでは予測しています。
MarketsandMarkets（マーケッツアンドマーケッツ）「ホームヘルスケア市場 : 製品（透析装置、人工呼吸器、HIV検査キット、補聴器、活動量計）、サービス（高度看護、点滴療法、緩和ケア）、適応症（がん、創傷ケア、糖尿病）、地域別 – 2028年までの世界予測 – Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region- Global Forecast to 2028」は在宅医療（ホームヘルスケア）市場を調査し、主要セグメント毎の分析・予測を提供します。
主な調査対象セグメント
- 製品
- 治療用製品
- 検査、スクリーニング、モニタリング用製品
- モビリティケア用製品
- サービス
- 高度看護
- リハビリテーション治療
- ホスピス&緩和ケア
- 単純ケア
- 呼吸療法
- 注入療法
- 妊婦ケア
- 適応症
- がん
- 呼吸器系疾患
- 運動障害
- 循環器疾患＆高血圧
- 妊娠
- 創傷ケア
- 糖尿病
- 聴覚障害
- その他
- 地域
- 北米
- 欧州
- アジア太平洋地域
- その他の地域（RoW）
- ラテンアメリカ
- 中東＆アフリカ
Report Overview
The global home healthcare market is projected to reach USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, at a CAGR of 8.9% during the forecast period.
of new technologies in home healthcare goods and services.
“The therapeutic products segment accounted for the highest growth rate in the home healthcare market, by product, during the forecast period.”
Products for testing, screening, and monitoring; products for therapy; and items for mobility care comprise the segments of the home healthcare market. The home healthcare market’s highest growth rate in 2022 was recorded by the therapeutic goods category. The increasing incidence of chronic illnesses is primarily responsible for market expansion.
“Infusion therapy services segment accounted for the highest CAGR.”
Skilled nursing, rehabilitation treatment, hospice & palliative care, unskilled care, respiratory therapy, infusion therapy, and prenatal care services are the several service categories that make up the home healthcare market. By 2022, the category with the highest growth rate was skilled nursing services. This is explained by both urbanization and population growth.
“Asia Pacific: The fastest-growing region home healthcare market.”
The global home healthcare market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. Over the course of the projection period, the Asia Pacific area is expected to record the greatest CAGR. factors including increased healthcare expenses and government attempts to support at-home care.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level (27%), Director-level (18%), and Others (55%)
• By Region: North America (51%), Europe (21%), Asia- Pacific (18%), Latin America (6%), and Middle East & Africa(4%)
The key players operating in this market include Fresenius SE & Co. KGaA (Germany), Abbott (US), GE
HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US), Linde plc (Ireland), F. Hoffman-La Roche, Ltd. (Switzerland), A&D Company Limited (Japan), Bayade Home Health Care (US), Invacare Corporation (US), Amedisys (US), LHC Group, Inc. (US), OMRON Corporation (Japan), Drive DeVilbiss Healthcare (UK), Sunrise Medical (Germany), Roma Medical (UK), CAREMAX Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Rflegedienst GmbH (Germany), RENAFAN GmbH (Germany), CONTEC MEDICAL SYSTEMS Co., Ltd. (China), B. Braun Melsungen Ag (Germany), Baxter International, Inc. (US), Medline Industries, Inc. (US), and Advin Health Care (India).
Research Coverage
This research report categorizes the home healthcare market by products, service, indicators, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the home healthcare market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the Surface disinfectant market. Competitive analysis of upcoming startups in the home healthcare market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall home healthcare market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (High prevalence of chronic diseases, growing geriatric population), restraints (Alternative Technologies), opportunities (Rising healthcare expenditure, Increasing Demand from Emerging Economies), and challenges (stringent regulations, limited insurance coverage) influencing the growth of the home healthcare market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the home healthcare market
• Market Development: Comprehensive information about lucrative markets – the report analyses the home healthcare market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the home healthcare market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US), among others in home healthcare market.
Table of Contents
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
TABLE 1 INCLUSIONS AND EXCLUSIONS 37
1.3 STUDY SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 REGIONS COVERED 39
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 39
1.4 STAKEHOLDERS 40
1.5 SUMMARY OF CHANGES 40
1.5.1 RECESSION IMPACT 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
2.2 RESEARCH APPROACH 42
FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY 42
2.2.1 SECONDARY DATA 43
2.2.1.1 Key data from secondary sources 43
2.2.2 PRIMARY DATA 44
TABLE 2 KEY DATA FROM PRIMARY SOURCES 45
2.2.2.1 Key industry insights 46
2.2.2.2 Breakdown of primary interviews 46
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE MARKET) 46
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.3 MARKET SIZE ESTIMATION 47
2.3.1 BOTTOM-UP APPROACH 47
2.3.1.1 Approach 1: Company revenue estimation approach 48
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 48
2.3.1.2 Approach 2: Presentations of companies and primary interviews 48
2.3.1.3 Growth forecast 48
2.3.1.4 CAGR projections 49
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 49
2.3.2 TOP-DOWN APPROACH 49
FIGURE 6 HOME HEALTHCARE MARKET: TOP-DOWN APPROACH 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 7 DATA TRIANGULATION METHODOLOGY 51
2.5 MARKET SHARE ANALYSIS 51
2.6 ASSUMPTIONS 52
2.7 GROWTH RATE ASSUMPTIONS 52
2.8 LIMITATIONS 52
2.9 RISK ASSESSMENT 53
2.10 RECESSION IMPACT ANALYSIS 53
3 EXECUTIVE SUMMARY 55
FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,
2023 VS. 2028 (USD BILLION) 55
FIGURE 9 HOME HEALTHCARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION) 56
FIGURE 10 HOME HEALTHCARE MARKET, BY SERVICE, 2023 VS. 2028 (USD BILLION) 56
FIGURE 11 HOME HEALTHCARE MARKET, BY INDICATION, 2023 VS. 2028 (USD BILLION) 57
FIGURE 12 HOME HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT 58
4 PREMIUM INSIGHTS 59
4.1 HOME HEALTHCARE MARKET OVERVIEW 59
FIGURE 13 RISING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH 59
4.2 GEOGRAPHIC GROWTH OPPORTUNITIES IN HOME HEALTHCARE MARKET 60
FIGURE 14 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 60
4.3 HOME HEALTHCARE MARKET: GEOGRAPHIC MIX 61
FIGURE 15 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 61
4.4 HOME HEALTHCARE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 62
FIGURE 16 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 17 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Rapid growth in elderly population and rising incidence of chronic diseases 64
TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION) 64
5.2.1.2 Rising R&D investments 65
TABLE 4 PRODUCT LAUNCHES 65
5.2.1.3 Need for cost-effective healthcare delivery due to rising costs 66
5.2.1.4 Increased preference for personalized care 66
5.2.2 RESTRAINTS 66
5.2.2.1 Changing reimbursement policies 66
5.2.2.2 Limited insurance coverage 67
5.2.2.3 Patient safety concerns 67
5.2.3 OPPORTUNITIES 68
5.2.3.1 Rising focus on telehealth 68
5.2.3.2 Untapped developing regions 69
5.2.3.3 Growing demand for home-use therapeutic devices 69
5.2.3.4 Growing demand for home sleep apnea tests 70
5.2.3.5 Rising preference for home hemodialysis treatment 71
5.2.4 CHALLENGES 71
5.2.4.1 Shortage of home care workers 71
5.2.4.2 Lack of supporting infrastructure 72
5.3 PRICING ANALYSIS 72
5.3.1 PRICING MODEL ANALYSIS 72
TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2023) 72
TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS, BY REGION (2023) 73
5.4 PATENT ANALYSIS 77
FIGURE 18 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2013–DECEMBER 2022) 77
5.4.1 LIST OF KEY PATENTS 78
5.5 VALUE CHAIN ANALYSIS 79
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 79
5.6 SUPPLY CHAIN ANALYSIS 80
FIGURE 20 HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS 81
5.7 ECOSYSTEM/MARKET MAP 81
FIGURE 21 HOME HEALTHCARE MARKET: ECOSYSTEM/MARKET MAP 82
5.7.1 HOME HEALTHCARE MARKET: ROLE IN ECOSYSTEM 82
5.8 PORTER’S FIVE FORCES ANALYSIS 83
5.8.1 PULSE OXIMETERS 83
TABLE 7 PULSE OXIMETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 83
5.8.1.1 Threat of new entrants 83
5.8.1.2 Threat of substitutes 84
5.8.1.3 Bargaining power of suppliers 84
5.8.1.4 Bargaining power of buyers 84
5.8.1.5 Degree of competition 84
5.8.2 HEARING AIDS 85
TABLE 8 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
5.8.2.1 Threat of new entrants 85
5.8.2.2 Threat of substitutes 85
5.8.2.3 Bargaining power of buyers 85
5.8.2.4 Bargaining power of suppliers 85
5.8.2.5 Degree of competition 85
5.9 PESTLE ANALYSIS 86
5.10 REGULATORY LANDSCAPE 87
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
5.10.1 NORTH AMERICA 89
5.10.1.1 US 89
TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES 89
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 90
5.10.1.2 Canada 90
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
FIGURE 23 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA 91
5.10.2 EUROPE 91
FIGURE 24 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES 92
5.10.3 ASIA PACIFIC 92
5.10.3.1 Japan 92
TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 93
5.10.3.2 China 93
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 94
5.10.3.3 India 95
5.11 TRADE ANALYSIS 96
5.11.1 TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS 96
TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION) 96
TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION) 96
5.12 TECHNOLOGY ANALYSIS 97
5.13 KEY CONFERENCES & EVENTS IN 2023–2024 98
TABLE 21 HOME HEALTHCARE MARKET: KEY CONFERENCES & EVENTS, 2023–2024 98
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 99
FIGURE 25 REVENUE SHIFT IN HOME HEALTHCARE 99
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 99
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS 99
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS 100
5.15.2 BUYING CRITERIA 100
FIGURE 27 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS 100
TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS 100
5.16 CASE STUDY ANALYSIS 101
5.16.1 CASE STUDY: FUTURE OF HOME HEALTH PROJECT 101
6 HOME HEALTHCARE MARKET, BY PRODUCT 102
6.1 INTRODUCTION 103
TABLE 24 HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 103
6.2 THERAPEUTIC PRODUCTS 103
TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED 104
TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
6.2.1 DIALYSIS EQUIPMENT 106
6.2.1.1 Dialysis equipment to hold largest market share 106
TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 107
6.2.2 WOUND CARE PRODUCTS 107
6.2.2.1 Decreased costs and higher convenience and comfort to drive market 107
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
6.2.3 IV EQUIPMENT 108
6.2.3.1 Accuracy and growing target disease prevalence to ensure market growth 108
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 109
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES 109
6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market 109
TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.2.5 INSULIN DELIVERY DEVICES 110
6.2.5.1 High incidence of diabetes to drive market 110
TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.2.6 OXYGEN DELIVERY SYSTEMS 111
6.2.6.1 Technological advancements in oxygen therapy products to drive market 111
TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
6.2.7 INHALERS 111
6.2.7.1 High incidence of asthma to boost market 111
TABLE 34 INHALERS MARKET, BY REGION, 2021–2028 (USD MILLION) 112
6.2.8 NEBULIZERS 112
6.2.8.1 Effectiveness over oral dosages to push preference for nebulizers 112
TABLE 35 NEBULIZERS MARKET, BY REGION, 2021–2028 (USD MILLION) 112
6.2.9 VENTILATORS 113
6.2.9.1 Convenience and comfort to sustain end-user preference 113
TABLE 36 VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 113
6.2.10 OTHER THERAPEUTIC PRODUCTS 114
TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2021–2028 (USD MILLION) 114
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS 114
TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED 115
TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 117
6.3.1 BLOOD GLUCOSE MONITORS 117
6.3.1.1 Increasing prevalence of diabetes to drive market growth 117
TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 118
6.3.2 HEARING AIDS 118
6.3.2.1 High incidence of hearing impairment to drive market 118
TABLE 42 HEARING AIDS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
6.3.3 ACTIVITY MONITORS & WRISTBANDS 119
6.3.3.1 Increasing prevalence of chronic diseases to bolster demand for activity monitors 119
TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
6.3.4 ECG/EKG DEVICES 120
6.3.4.1 High prevalence of CVD to support demand 120
TABLE 44 ECG/EKG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 120
6.3.5 TEMPERATURE MONITORING DEVICES 121
6.3.5.1 Technological innovations and increasing awareness to drive growth 121
TABLE 45 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 121
6.3.6 HEART RATE MONITORS 122
6.3.6.1 Continuous cardiac parameter monitoring capabilities to drive demand 122
TABLE 46 HEART RATE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
6.3.7 PULSE OXIMETERS 122
6.3.7.1 Rising disease incidence and wide usage of pulse oximetry to ensure strong demand 122
TABLE 47 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 123
6.3.8 OVULATION & PREGNANCY TEST KITS 123
6.3.8.1 Privacy, convenience, accessibility, and quick results to drive market 123
TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 123
6.3.9 BLOOD PRESSURE MONITORS 124
6.3.9.1 Rising patient population for hypertension and CVD to drive market 124
TABLE 49 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 124
6.3.10 HIV TEST KITS 125
6.3.10.1 Rising prevalence of HIV to drive market 125
TABLE 50 HIV TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 125
6.3.11 FETAL MONITORING DEVICES 125
6.3.11.1 Remote-based care by portable fetal monitoring systems to drive market growth 125
TABLE 51 FETAL MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 126
6.3.12 HOLTER & EVENT MONITORS 127
6.3.12.1 Rising awareness of preventive care and technological advancements to drive market 127
TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 127
6.3.13 DRUG & ALCOHOL TEST KITS 127
6.3.13.1 Rising consumption of drugs among teens to support market growth 127
TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 128
6.3.14 COAGULATION MONITORING PRODUCTS 128
6.3.14.1 Rising use of anticoagulant therapy and availability of home-use kits to drive market 128
TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 129
6.3.15 PEAK FLOW METERS 129
6.3.15.1 High portability and cost-efficiency to ensure adoption 129
TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.3.16 COLON CANCER TEST KITS 130
6.3.16.1 High incidence of colorectal cancer to drive market growth 130
TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.3.17 EEG DEVICES 131
6.3.17.1 Wide patient population for epilepsy to drive market for EEG devices 131
TABLE 57 EEG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 131
6.3.18 HOME SLEEP TESTING DEVICES 131
6.3.18.1 Cost-effectiveness of home-based sleep tests to fuel growth 131
TABLE 58 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.3.19 CHOLESTEROL TESTING PRODUCTS 133
6.3.19.1 Rising obesity levels and CVD incidence to support market 133
TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.3.20 HOME HBA1C TEST KITS 133
6.3.20.1 High incidence of diabetes to drive market 133
TABLE 60 HOME HBA1C TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.4 MOBILITY CARE PRODUCTS 134
TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET 134
TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
6.4.1 WHEELCHAIRS 136
6.4.1.1 Increased preference for wheelchairs to boost demand 136
TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
6.4.2 MOBILITY SCOOTERS 137
6.4.2.1 High cost to affect end-user adoption 137
TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
6.4.3 WALKERS & ROLLATORS 138
6.4.3.1 Difficulties in using walkers and availability of alternatives to restrain market 138
TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
6.4.4 CRUTCHES 138
6.4.4.1 High preference for axilla crutches to support demand 138
TABLE 67 CRUTCHES MARKET, BY REGION, 2021–2028 (USD MILLION) 139
6.4.5 CANES 139
6.4.5.1 Wide usage of canes to drive market 139
TABLE 68 CANES MARKET, BY REGION, 2021–2028 (USD MILLION) 139
7 HOME HEALTHCARE MARKET, BY SERVICE 140
7.1 INTRODUCTION 141
TABLE 69 US: AVERAGE SENIOR CARE COST, BY TYPE, 2022 141
TABLE 70 HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 142
TABLE 71 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 142
7.2 SKILLED NURSING SERVICES 143
7.2.1 SKILLED NURSING SERVICES TO DOMINATE MARKET 143
TABLE 72 SKILLED NURSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 143
7.3 REHABILITATION THERAPY SERVICES 144
7.3.1 RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND 144
TABLE 73 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 144
7.4 HOSPICE & PALLIATIVE CARE SERVICES 144
7.4.1 RISING GERIATRIC POPULATION TO DRIVE DEMAND 144
TABLE 74 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 145
7.5 UNSKILLED CARE SERVICES 145
7.5.1 COST-EFFECTIVENESS TO DRIVE GROWTH 145
TABLE 75 UNSKILLED SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 146
7.6 RESPIRATORY THERAPY SERVICES 146
7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET 146
TABLE 76 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 147
7.7 INFUSION THERAPY SERVICES 147
7.7.1 SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND 147
TABLE 77 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 148
7.8 PREGNANCY CARE SERVICES 148
7.8.1 NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH 148
TABLE 78 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 149
8 HOME HEALTHCARE MARKET, BY INDICATION 150
8.1 INTRODUCTION 151
TABLE 79 HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 151
TABLE 80 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 151
8.2 CANCER 152
8.2.1 CANCER TO DOMINATE INDICATIONS MARKET 152
TABLE 81 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 152
TABLE 82 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION) 153
8.3 RESPIRATORY DISEASES 153
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 153
TABLE 83 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021–2028 (USD MILLION) 154
8.4 MOVEMENT DISORDERS 154
8.4.1 GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT 154
TABLE 84 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021–2028 (USD MILLION) 155
8.5 PREGNANCY 155
8.5.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH 155
TABLE 85 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2021–2028 (USD MILLION) 156
8.6 CVD & HYPERTENSION 156
8.6.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH 156
TABLE 86 HOME HEALTHCARE MARKET FOR CVD & HYPERTENSION, BY REGION, 2021–2028 (USD MILLION) 157
8.7 WOUND CARE 157
8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET 157
TABLE 87 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2021–2028 (USD MILLION) 158
8.8 DIABETES 158
8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH 158
TABLE 88 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION) 159
8.9 HEARING DISORDERS 159
8.9.1 WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH 159
TABLE 89 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021–2028 (USD MILLION) 159
8.10 OTHER INDICATIONS 160
TABLE 90 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION) 160
9 HOME HEALTHCARE MARKET, BY REGION 161
9.1 INTRODUCTION 162
TABLE 91 HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 162
9.2 NORTH AMERICA 162
9.2.1 NORTH AMERICA: RECESSION IMPACT 162
FIGURE 28 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT 163
TABLE 92 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 93 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 164
TABLE 94 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 95 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 96 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 97 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 98 NORTH AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 167
TABLE 99 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 168
9.2.2 US 168
9.2.2.1 US to dominate North American home healthcare market 168
TABLE 100 US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 169
TABLE 101 US: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 170
TABLE 102 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 103 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 104 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 105 US: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 172
TABLE 106 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 173
9.2.3 CANADA 173
9.2.3.1 Rising geriatric population to drive market 173
TABLE 107 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 174
TABLE 108 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 109 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 110 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 111 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 112 CANADA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 177
TABLE 113 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 178
9.3 EUROPE 178
9.3.1 EUROPE: RECESSION IMPACT 179
TABLE 114 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 115 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 180
TABLE 116 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 180
TABLE 117 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 118 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 119 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 120 EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 183
TABLE 121 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 184
9.3.2 GERMANY 184
9.3.2.1 Germany to retain market leadership in Europe 184
TABLE 122 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 185
TABLE 123 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 185
TABLE 124 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 125 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 126 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 127 GERMANY: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 188
TABLE 128 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 189
9.3.3 UK 189
9.3.3.1 Rising burden of chronic diseases to boost market growth 189
TABLE 129 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 190
TABLE 130 UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 131 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 132 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 133 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 134 UK: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 193
TABLE 135 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 194
9.3.4 FRANCE 194
9.3.4.1 Government support and initiatives taken by market players to boost market 194
TABLE 136 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 195
TABLE 137 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195
TABLE 138 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 139 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 140 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 141 FRANCE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 198
TABLE 142 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 199
9.3.5 ITALY 199
9.3.5.1 Rising geriatric population and favorable government policy to drive market 199
TABLE 143 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 200
TABLE 144 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 200
TABLE 145 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 146 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 147 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 148 ITALY: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 203
TABLE 149 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 204
9.3.6 SPAIN 204
9.3.6.1 Rising geriatric population and incidence of chronic conditions to drive market growth 204
TABLE 150 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 205
TABLE 151 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 205
TABLE 152 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 153 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 154 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 155 SPAIN: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 208
TABLE 156 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 209
9.3.7 REST OF EUROPE 209
TABLE 157 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 210
TABLE 158 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210
TABLE 159 REST OF EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 160 REST OF EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 161 REST OF EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 162 REST OF EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 213
TABLE 163 REST OF EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 214
9.4 ASIA PACIFIC 214
9.4.1 ASIA PACIFIC: RECESSION IMPACT 215
FIGURE 29 APAC: HOME HEALTHCARE MARKET SNAPSHOT 215
TABLE 164 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 165 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 216
TABLE 166 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 217
TABLE 167 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 168 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 169 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 170 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 219
TABLE 171 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 220
9.4.2 JAPAN 220
9.4.2.1 Japan to command largest share of APAC market 220
TABLE 172 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 221
TABLE 173 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 221
TABLE 174 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 175 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 176 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 177 JAPAN: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 224
TABLE 178 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 225
9.4.3 CHINA 225
9.4.3.1 Healthcare development and reforms to drive market growth 225
TABLE 179 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 226
TABLE 180 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 226
TABLE 181 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 182 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 183 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 184 CHINA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 229
TABLE 185 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 230
9.4.4 INDIA 230
9.4.4.1 Increasing target patient population to drive market 230
TABLE 186 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 231
TABLE 187 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 231
TABLE 188 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 189 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 190 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 191 INDIA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 234
TABLE 192 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 235
9.4.5 REST OF ASIA PACIFIC 235
TABLE 193 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 236
TABLE 194 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 236
TABLE 195 REST OF ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 196 REST OF ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 197 REST OF ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 198 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 239
TABLE 199 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 240
9.5 REST OF THE WORLD 240
9.5.1 REST OF THE WORLD: RECESSION IMPACT 240
TABLE 200 ROW: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 241
TABLE 201 ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 241
TABLE 202 ROW: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 242
TABLE 203 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 204 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 205 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 206 ROW: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 244
TABLE 207 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 245
9.5.2 LATIN AMERICA 245
9.5.2.1 Aging population to favor market growth 245
TABLE 208 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 246
TABLE 209 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 246
TABLE 210 LATIN AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 211 LATIN AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 212 LATIN AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 213 LATIN AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 249
TABLE 214 LATIN AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 250
9.5.3 MIDDLE EAST & AFRICA 250
TABLE 215 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 251
TABLE 216 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 251
TABLE 217 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 252
TABLE 218 MIDDLE EAST & AFRICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 219 MIDDLE EAST & AFRICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 220 MIDDLE EAST & AFRICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 221 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 254
TABLE 222 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 255
9.5.3.1 GCC Countries 255
9.5.3.1.1 Rising focus on expanding and improving health infrastructure to drive market 255
TABLE 223 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 256
TABLE 224 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 256
TABLE 225 GCC COUNTRIES: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 226 GCC COUNTRIES: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 227 GCC COUNTRIES: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 228 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 259
TABLE 229 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 260
9.5.3.2 Rest of the Middle East & Africa 260
TABLE 230 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 261
TABLE 231 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 261
TABLE 232 ROMEA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 233 ROMEA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 234 ROMEA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 235 ROMEA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION) 264
TABLE 236 ROMEA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION) 265
10 COMPETITIVE LANDSCAPE 266
10.1 OVERVIEW 266
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 266
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS 266
TABLE 237 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HOME HEALTHCARE PRODUCT MANUFACTURERS 266
10.3 REVENUE SHARE ANALYSIS 268
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS 268
10.4 MARKET SHARE ANALYSIS 269
FIGURE 31 HOME HEALTHCARE MARKET SHARE ANALYSIS (2022) 269
TABLE 238 HOME HEALTHCARE MARKET: DEGREE OF COMPETITION 269
10.5 COMPANY EVALUATION MATRIX 270
10.5.1 STARS 270
10.5.2 EMERGING LEADERS 270
10.5.3 PERVASIVE PLAYERS 270
10.5.4 PARTICIPANTS 271
FIGURE 32 HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX, 2022 271
10.5.5 COMPANY FOOTPRINT 272
TABLE 239 PRODUCT FOOTPRINT (FIVE PLAYERS) 272
TABLE 240 REGIONAL FOOTPRINT (FIVE PLAYERS) 272
TABLE 241 COMPETITIVE BENCHMARKING OF KEY PLAYERS 273
FIGURE 33 COMPANY FOOTPRINT (FIVE COMPANIES) 273
10.6 START-UP/SME EVALUATION MATRIX 273
10.6.1 PROGRESSIVE COMPANIES 273
10.6.2 RESPONSIVE COMPANIES 273
10.6.3 DYNAMIC COMPANIES 274
10.6.4 STARTING BLOCKS 274
FIGURE 34 HOME HEALTHCARE MARKET: START-UP/SME EVALUATION MATRIX, 2022 274
10.6.5 COMPETITIVE BENCHMARKING 275
TABLE 242 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES 275
TABLE 243 COMPETITIVE BENCHMARKING OF START-UPS/SMES 276
10.7 COMPETITIVE SCENARIO 276
10.7.1 PRODUCT LAUNCHES & APPROVALS 276
TABLE 244 HOME HEALTHCARE MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 276
10.7.2 DEALS 277
TABLE 245 HOME HEALTHCARE MARKET: DEALS (JANUARY 2020–DECEMBER 2023) 277
10.7.3 OTHER DEVELOPMENTS 278
TABLE 246 HOME HEALTHCARE MARKET: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 278
11 COMPANY PROFILES 279
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 279
11.1.1 FRESENIUS SE & CO. KGAA 279
TABLE 247 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW 279
FIGURE 35 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2022) 280
TABLE 248 FRESENIUS SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 280
TABLE 249 FRESENIUS SE & CO. KGAA: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 281
TABLE 250 FRESENIUS SE & CO. KGAA: DEALS (JANUARY 2020–DECEMBER 2023) 282
TABLE 251 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 282
11.1.2 ABBOTT 284
TABLE 252 ABBOTT: COMPANY OVERVIEW 284
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2022) 285
TABLE 253 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285
TABLE 254 ABBOTT: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 286
TABLE 255 ABBOTT: DEALS (JANUARY 2020–DECEMBER 2023) 287
11.1.3 LINDE PLC 288
TABLE 256 LINDE: COMPANY OVERVIEW 288
FIGURE 37 LINDE: COMPANY SNAPSHOT (2022) 289
TABLE 257 LINDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 289
11.1.4 F. HOFFMANN-LA ROCHE 291
TABLE 258 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW 291
FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022) 292
TABLE 259 F. HOFFMAN-LA ROCHE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292
TABLE 260 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES
(JANUARY 2020–DECEMBER 2023) 293
TABLE 261 F. HOFFMANN-LA ROCHE: DEALS (JANUARY 2020–DECEMBER 2023) 293
11.1.5 RESMED 295
TABLE 262 RESMED: COMPANY OVERVIEW 295
FIGURE 39 RESMED: COMPANY SNAPSHOT (2022) 296
TABLE 263 RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 297
TABLE 264 RESMED: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 298
TABLE 265 RESMED: DEALS 298
11.1.6 KONINKLIJKE PHILIPS 300
TABLE 266 KONINKLIJKE PHILIPS: COMPANY OVERVIEW 300
FIGURE 40 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2022) 301
TABLE 267 KONINKLIJKE PHILIPS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 301
TABLE 268 KONINKLIJKE PHILIPS: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 303
TABLE 269 KONINKLIJKE PHILIPS: DEALS (JANUARY 2020–DECEMBER 2023) 303
11.1.7 GE HEALTHCARE 305
TABLE 270 GE HEALTHCARE: COMPANY OVERVIEW 305
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 306
TABLE 271 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 306
TABLE 272 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023) 308
11.1.8 A&D COMPANY 309
TABLE 273 A&D COMPANY: COMPANY OVERVIEW 309
FIGURE 42 A&D COMPANY: COMPANY SNAPSHOT (2022) 310
TABLE 274 A&D COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 310
TABLE 275 A&D COMPANY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 311
11.1.9 INVACARE CORPORATION 312
TABLE 276 INVACARE CORPORATION: COMPANY OVERVIEW 312
FIGURE 43 INVACARE CORPORATION: COMPANY SNAPSHOT (2022) 313
TABLE 277 INVACARE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 313
TABLE 278 INVACARE CORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 315
11.1.10 AMEDISYS 316
TABLE 279 AMEDISYS: COMPANY OVERVIEW 316
FIGURE 44 AMEDISYS: COMPANY SNAPSHOT (2022) 317
TABLE 280 AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 317
TABLE 281 AMEDISYS: DEALS (JANUARY 2020–DECEMBER 2023) 318
11.1.11 LHC GROUP 320
TABLE 282 LHC GROUP: COMPANY OVERVIEW 320
FIGURE 45 LHC GROUP: COMPANY SNAPSHOT (2022) 320
TABLE 283 LHC GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 321
TABLE 284 LHC GROUP: DEALS (JANUARY 2020–DECEMBER 2023) 323
11.1.12 OMRON CORPORATION 325
TABLE 285 OMRON CORPORATION: COMPANY OVERVIEW 325
FIGURE 46 OMRON CORPORATION: COMPANY SNAPSHOT (2022) 326
TABLE 286 OMRON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 326
TABLE 287 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 329
TABLE 288 OMRON CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 329
11.2 OTHER PLAYERS 330
11.2.1 BAYADA HOME HEALTH CARE 330
11.2.2 DRIVE DEVILBISS HEALTHCARE LIMITED 331
11.2.3 SUNRISE MEDICAL 332
11.2.4 ROMA MEDICAL 334
11.2.5 CAREMAX REHABILITATION EQUIPMENT 336
11.2.6 VITALOGRAPH 337
11.2.7 ADVITA PFLEGEDIENST 338
11.2.8 RENAFAN GMBH 338
11.2.9 CONTEC MEDICAL SYSTEMS 339
11.2.10 B. BRAUN MELSUNGEN AG 340
11.2.11 BAXTER INTERNATIONAL 341
11.2.12 MEDLINE INDUSTRIES 342
11.2.13 ADVIN HEALTH CARE 343
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 344
12.1 DISCUSSION GUIDE 344
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 349
12.3 CUSTOMIZATION OPTIONS 351
12.4 RELATED REPORTS 351
12.5 AUTHOR DETAILS 352